Trials / Completed
CompletedNCT05278676
A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants
A Single and Multiple Dose Pharmacokinetic Study of Dotinurad in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to evaluate the pharmacokinetics (PK) of dotinurad following single and multiple oral doses of dotinurad in Chinese healthy male and female participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dotinurad | Dotinurad oral tablet. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2022-12-13
- Completion
- 2022-12-13
- First posted
- 2022-03-14
- Last updated
- 2023-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05278676. Inclusion in this directory is not an endorsement.